ClinVar Miner

Submissions for variant NM_001009944.3(PKD1):c.10810G>A (p.Glu3604Lys)

dbSNP: rs2091722550
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute RCV001251489 SCV001427141 likely pathogenic Polycystic kidney disease, adult type 2018-12-12 criteria provided, single submitter clinical testing A heterozygous missense variant, NM_001009944.2(PKD1):c.10810G>A, has been identified in exon 36 of 46 of the PKD1 gene. The variant is predicted to result in a minor amino acid change from glutamic acid to lysine at position 3604 of the protein (NP_001009944.2(PKD1):p.(Glu3604Lys)). The glutamic acid residue at this position has high conservation (100 vertebrates, UCSC), but is not located within a well established functional domain. In silico predictions for this variant are consistently pathogenic (Polyphen, SIFT, CADD, Mutation Taster). The variant is absent in population databases (gnomAD, dbSNP, 1000G) but has been previously described as pathogenic in one patient with polycystic kidney disease (Rossetti, S. et al. (2007)). Based on the information available at the time of curation, this variant has been classified as LIKELY PATHOGENIC.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.